Use the content type and topic filters to narrow down results
Artificial intelligence (AI) is transforming how life sciences organizations approach drug development, diagnostics, personalized care and more. Now, many are exploring how AI can enhance patient support programs (PSPs) by improving efficiency, patient and healthcare provider experiences and improved outcomes. In this Drug Channels Institute article, Chief Product Officer William...
Tech-first therapy initiation and patient solutions provider enhances and augments services with artificial intelligence-powered patient engagement. Orlando, Fla. – April 2, 2025 – AssistRx, the advanced therapy initiation and patient solutions provider, today announced it has completed an asset acquisition from AllazoHealth, a healthcare technology company driving therapy initiation, adherence...
Since early 2024, life sciences organizations have increasingly adopted direct-to-consumer (DTC) models to simplify patient access, reduce costs and address market challenges. While DTC models offer advantages in convenience and market positioning, it also introduces complexities in implementation, compliance and data security.In this Drug Channels Institute article, Vice President of...
Be the first to access resources and insights on how to drive timely therapy access, improved ongoing patient support, and enhanced provider and patient experiences.
Input your search keywords and press Enter.